Navigation Links
Novo Nordisk Appoints Alan C. Moses as Chief Medical Officer Worldwide
Date:1/9/2008

PRINCETON, N.J., Jan. 9 /PRNewswire-FirstCall/ -- Novo Nordisk, a healthcare company with an 84-year history of innovation and achievement in diabetes care, today announced the appointment of Alan C. Moses, M.D. as vice president, chief medical officer worldwide. Moses is currently the chief medical officer of Novo Nordisk Inc., the company's U.S. affiliate.

"Alan has the unique talent to integrate the science of discovery with new drug development -- a critical asset that will deepen Novo Nordisk's leadership position in changing diabetes," said Mads Krogsgaard Thomsen, executive vice president and chief science officer for Novo Nordisk A/S. "The broadening of Novo Nordisk's diabetes therapeutic portfolio with the development of liraglutide and other novel molecules in the pipeline, and the increasing importance of the U. S. to the Novo Nordisk business, requires a leader with clinical and research expertise to assume the role of chief medical officer."

In the newly expanded role, Moses will work closely with senior colleagues in Denmark to serve as the principle voice of clinical science for the company worldwide, providing clinical and medical affairs expertise.

"Novo Nordisk and the diabetes community in the U.S. have been fortunate to have Alan lead the efforts for the company in changing diabetes, and now, with his expanded responsibilities, the world will benefit from Alan's passion for research and advocacy for finding better ways for people to live with the disease," said Dr. Henrik Rasmussen, vice president of clinical development, medical and regulatory affairs, Novo Nordisk Inc.

Moses was formerly senior vice president and chief medical officer at the Joslin Diabetes Center and joined Novo Nordisk in April 2004 as associate vice president of medical affairs and since then has also assumed responsibility for clinical research in diabetes. Prior to joining Novo Nordisk, Dr. Moses spent 23 years at Harvard Medical School-a
'/>"/>

SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
2. Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
3. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
4. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
5. Ikaria Appoints Daniel Tasse as President and Chief Executive Officer
6. SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer
7. Mersana Therapeutics Appoints C. Boyd Clarke Chairman of the Board of Directors
8. Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
9. Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
10. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
11. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Em...: EMDY), a leading,producer and distributor of inf...n products in China, today announced that the Comp...d & Drink Executive, a quarterly magazine with...od and beverage industry. , The article, ...
(Date:12/2/2009)...ire-Asia/ -- The world is going through,extraordin...is part of many,businesses and industries. It turn... immune to the economic downturn, because illness ...st of the difficult times this year, the pharmaceu...&D center in Shanghai, the largest of,its kind...
(Date:12/1/2009)...announced that he has joined Carolina Eyecare Phys... www.DrKerrySolomon.com , which was developed by M...LASIK, lens implant, and cataract surgery expert w...tantial contributions to improving vision correcti...ons, which screens LASIK surgeons based upon exper...
(Date:12/1/2009)...re/ -- Reportlinker.com announces that a new marke..., Industrial Enzymes - A Global Market Report ...trial-Enzymes---A-Global-Market-Report.html ,,...w strong players and a host of small suppliers eng...and commoditization characterize the industry. Raz...
Breaking Biology Technology:Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
...nounced that the breakthrough bio-based ingredient...valuated by NSF International and now is listed in....S. Environmental Protection Agency (EPA) Design f...oduced and marketed by the DuPont Tate & Lyle ... Loudon, TN (Vocus) December 30, 2008 -- DuPon...
...Q4 2008 , - Evaluation of strategic alternatives o...ard Role , , SAN DIEGO, Jan. 5 ADVENTRX Pharmace...oday that it has implemented a further reduction-i...and to prepare itself for a strategic transaction....2008. In all, the Company,s workforce has decline...
...obzhansky, the late great geneticist and evolution...akes sense except in the light of evolution." , ,...win (February 12, 1809) and the 150th anniversary ...ch laid out the theory of evolution by means of na... academic centers, and other scientific organizati...
Other Biology Technology:Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria 2Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria 3ADVENTRX Announces Further Cost-Cutting Measures 2ADVENTRX Announces Further Cost-Cutting Measures 3ADVENTRX Announces Further Cost-Cutting Measures 4ADVENTRX Announces Further Cost-Cutting Measures 5GEN Joins Charles Darwin 2009 Celebration 2
(Date:12/2/2009)..., , REDWOOD CITY, Calif., Dec. 2 /PRNewswir...t identity and authentication solutions, today ann... of its DigitalPersona biometric fingerprint techn...alPersona U.are.U® 4500HD offering allows poi... identify users so that specific transactions can ...
(Date:12/2/2009)..., A scientist from the University of Salamanca and...presence of predators affects the behaviour of Ac...m the Negev Desert in the Near East. According to ... mobile and different prey if they are under press...d predicted this result, but until now there had b...
(Date:12/1/2009)...December 1, 2009: OptiNose is pleased to announce ...cal study investigating the efficacy and tolerabil...or the topical treatment of chronic rhinosinusitis...urnal of the International and European Rhinologic... polyps is a chronic disease that can significantl...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Lizards change their diet to avoid predators 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2DNA mutations linked to diabetes 9759 1Dr David Okrongly Appointed CEO of Quanterix Corporation 56003 1Dr David Okrongly Appointed CEO of Quanterix Corporation 56003 2BioMarin to Present at the Baird Healthcare Conference 13799 1BioMarin to Present at the Baird Healthcare Conference 13799 2
... December 1st issue of G&D detail how human RecQ h...tect genome stability. , The human RecQ family o...4, RECQL1 and RECQL5. These enzymes help to unwind...nd DNA repair. Mutations in BLM, WRN and RECQ4 cau...rome, Werners Syndrome and Rothmund-Thomson Syndro...
...been selected to receive the Albert Maucher Prize ...n Research Foundation) in honour of their outstand...n 8 November 2007 to Dr. Martin Blumenberg from th...y at the University of Hamburg, who received the p...n, and Dr. David Dolejs from the Bavarian Research...
... Fingerprint Sensor Recognized in the ... CLARA, Calif., Nov. 13 Synaptics Inc.,(Nasdaq: ...utions for mobile,computing, communications and en...rePad(TM) solution has been selected as a CES Inno...ling Technologies product category. The,highly sou...
Other Biology News:2007 Albert Maucher Prize for Outstanding Young Geoscientists 2Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree 2Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree 3
Sheep Serum from CHEMICON
Eppendorf tube holder, for Tube rack 175 x 12 mm from GE Healthcare, formerly Amersham Biosciences
...aline Phosphatase, Calf Intestinal (CIAP), catalyz...RNA, and ribo- and deoxyribonucleoside triphosphat...on and religation of linearized cloning vector DNA...and may also be used for the dephosphorylation of ...
Agarose, pulse field from GE Healthcare, formerly Amersham Biosciences
Biology Products: